期刊文献+

血浆D二聚体测定的量值比较与一致性研究 被引量:1

Quantitative Analysis and Correspondence of Different D-dimer Reagents in Clinical Use
下载PDF
导出
摘要 目的 调查D二聚体定量试剂检测临床标本的性能,探讨开展质量评估的可能性.方法 分别使用STA Liatest、Innovance D-二聚体和HS500三种试剂检测149例临床标本血浆D二聚体,分为0.2~1.00、1.01~4.00和4.01 ~ 20 mg/L三浓度区间统计方法间的偏差和在中高值区间的相关性,并以cutoff值(0.5 mg/L)作为定性判断的依据判断阴性符合率.结果 Innovance、HS500与Liatest相比,低值区间偏差低于0.05 mg/L,中值区间偏差为0.75和0.87mg/L,高值区间2.18和1.82 mg/L;线性关系具有统计学意义,分别为y=1.14x+0.18(r=0.92,P<0.01)和y=0.96x+ 0.59(r=0.863,P<0.01).以0.5 mg/L为cutoff值,两者与Liatest相比的阴性符合率为91.4%和80%,总体符合率为94%和89%.结论 三种血浆D二聚体定量检测作静脉血栓定性的定性筛查时有较高符合率,同时其定量结果的一致性为开展质量评价提供了前提. Objective To investigate performance of major quantitative reagents in plasma D-Dimer analysis from clinical patients,looking for the feasibility of quality assessment in D-dimer.Methods Plasma from 149 patients were collected and analyzed.Biases in 0.2 ~ 1.00,1.01 ~4.00 and 4.01 ~20 mg/L three consecutive levels of D-dimer concentration,correlations in higher level(> 1.0 mg/L) and correspondence around cutoff(0.5 mg/L)between methods are calculated.Results Compared with Liatest D-dimer,Biases from innovance and HS 500 are less than 0.05 in 0.2-1.00 mg/L,0.75 and 0.87 mg/L in median,2.18 and 1.82 mg/L in high level.The statistical linearity lie in y =1.14 x + 0.18(r =0.92,P <0.01)from innovance and y =0.96 x + 0.59(r =0.863,P < 0.01)from HS 500,negative coincidence rates are 91.4% and 80%,respectively,and higher total coincidence are 94% and 89%.Conclusion As measure in excluding diagnostic of venous thromboembolism,reagents investigated show their conformability on basis of clinical evaluation,and suggest the probability for quality assessment in D-Dimer.
出处 《血栓与止血学》 2014年第5期243-246,共4页 Chinese Journal of Thrombosis and Hemostasis
关键词 D二聚体 静脉栓塞 质量评价 D-dimer Venous thromboembolism Quality assessment
  • 相关文献

参考文献16

  • 1HEIM SW,SCHECTMAN JM,SIADATY MS,et al.D-dimer testing for deep venous thrombosis:a metaanalysis[J].Clin Chem,2004,50(11):36-47.
  • 2STEIN PD,HULL RD,PATEL KC,,et al.D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism-a systematic review[J].Ann Intern Med 2004,140:589-602.
  • 3PERRIER A,PALARETI G.D-dimer testing and venous thromboembolism:four view points[J].J Thromb Haemost,2005,3:382-384.
  • 4WASER G,KATHRINER S.WUILLEMIN WA.Performance of the automated and rapid STA Liatest D-dimer on the STA-R analyzer[J].Thromb Res,2005,116 (2):165-170.
  • 5DE MOERLOOSE,P.,PALARETI,G.AGUILAR,C.,et al.A multicenter evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism[J].Thromb haemost,2008,100 (3):505-512.
  • 6LEGNANI,C.,CINI,M.SCARVELIS,D.,et al.Multicenter evaluation of a new quantitative highly sensitive D-dimer assay,the Hemosil D-dimer HS 500,in patients with clinically suspected venous thromboembolism[J].Thromb Res,2010,125(5):398-401.
  • 7Guidelines on the diagnosis and management of acute pulmonary embolism:the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)[J].Eur Heart J,2008 ; 29:2276-2315.
  • 8LEGNANI C,CINI M,SCARVELIS D,et al..Multicenter evaluation of a new quantitative highly sensitive D-dimer assay,the Hemosil D-dimer HS 500,in patients with clinically suspected venous thromboembolism[J].Thromb Res,2010,125(5):398-401.
  • 9HERAK DC,MILOS M,ZADRO R.Evaluation of the Innovance D-dimer analytical performance[J].Clin Chem Lab M ed,2009,47 (8):945-951.
  • 10DE MAAT MP,MEIJER P,NIEUWENHUIZEN W,et al.Performance of semiquantitative and quantitative D-dimer assays in the ECAT external quality assessment program[J].Semin Thromb Hemost,2000,26:625-630.

二级参考文献12

  • 1DEMPFLE CE. D-dimer: standardization versus harmonization [ J ]. Thromb Haemost ,2006,95 (3) :399-400.
  • 2DEMPFLE CE. D-dimer assays: the current status and newassay technologies [ J ]. Thromb Res,2006,118:569-710.
  • 3BOUNAMEAUX H, SCHNEIDER PA, REBER G,et al. Measurement of plasma D-dimer for diagnosis of deep ve~ous thr,~.~h~sis[ J]o Am J Clin Pathol, 1989,91 : 82-85.
  • 4DEMPFLE CE,ZIPS S, ERGUL H, et al. The Fibrin Assay Compari- son Trial (FACT) : evaluation of 23 quantitative D- Dimer assays as basis for the development of D- Dimer calibrator FACT study group [ J]. Thromb Haemost ,2001,85:671-678.
  • 5GAFFNEY PJ, CREIGHTON LJ, CALLUS, M. et al. Monoclonal anti- bodies to crosslinked fibrin degradation products (XL-FDP). II. Eval- uation in a variety of clinical conditions [ J ]. British Journal of Haem- atology, 1988,68,91 -96.
  • 6ROWBOTHAM BJ, CARROLL P, WHITAKER AN, et al. Measure- ment of crosslinked fibrin derivatives use in the diagnosis of venous thrombosis[ J]. Thromb Haemost, 1987,57:59-61.
  • 7DESIREE CH, MARIJA MRZ. Evaluation of the Innovance D-DIMER analytical performance [ J 1. Clin Chem Lab Med, 2009,47 ( 8 ) : 945- 951.
  • 8REBER G, de MOERLOOSE P. D-Dimer assays for the exclusion of venous thromboembolism [ J ]. Sem Thromb Hemost, 2000, ~6 : 619- 624.
  • 9CHRIS G, CORALIE P, CLAIRE W. An evaluation of rapid D-dimer assays for the exclusion of deep vein thrombosis[ J]. British Journal of Haematology, 128,842 - 848.
  • 10LENNART R. KLAUS D. Comparative evaluation of difterent D-dimer assays for exclusion of venous thromboembolism in a clinical routine setting[ J]. J Lab Med ,2008,32 (3) :215-217.

共引文献5

同被引文献8

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部